Odd‐Chain Dicarboxylic Acid Feeding Produces a Glutaric Aciduria Type 1–Like Metabolic Signature in Mice

Glutaric aciduria type-1 (GA1) is an inherited mitochondrial neurometabolic disorder with a poorly understood pathogenesis and unmet medical needs. GA1 can be diagnosed via its hallmark biochemical signature consisting of glutaric aciduria, 3-hydroxyglutaric aciduria, and increased plasma glutarylcarnitine. These glutaryl-CoA-derived metabolites are thought to originate solely in the mitochondria. Here, we demonstrate that wild-type mice fed an 11-carbon odd-chain dicarboxylic acid (undecanedioic acid, DC₁₁) recreate the biochemical phenotype of GA1. Odd-chain dicarboxylic acids like DC₁₁ are not present in food but can arise from several endogenous processes, such as lipid peroxidation and fatty acid ω-oxidation. DC₁₁ is chain-shortened in peroxisomes to glutaryl (DC₅)-CoA, which then gives rise to the GA1-like pattern of DC₅ metabolites in urine, tissues, and blood. Glutaric acid released from peroxisomes during DC₁₁ chain-shortening can enter mitochondria for reactivation by the enzyme succinyl-CoA:glutarate-CoA transferase (SUGCT) and become substrate for glutaryl-CoA dehydrogenase (GCDH), the enzyme that is deficient in GA1. Our data provide proof-of-concept that the generation of dicarboxylic acids by ω-oxidation, which is stimulated during the same catabolic states known to trigger acute encephalopathy in GA1, may exacerbate disease by increasing the glutaryl-CoA substrate load in mitochondria.